The Future of the U.S. Biosimilars Market: Development, Education, and Utilization October 18, 2016 - 9:00 am to 12:30 pm The Ritz-Carlton 1150 22nd St NW, Washington, DC PLEASE NOTE: Change in Location Ritz-Carlton 1150 22nd... Biomedical Innovation
Exploring Novel Statistical Methods for Rare Disease and Small Population Clinical Trials October 11, 2016 (All day) ACC Heart House 2400 N St NW, Washington, DC Duke-Margolis will convene a private statistical expert workshop focused on exploring the...
Do antimicrobial development and reimbursement models make sense to payers? September 8, 2016 (All day) to September 9, 2016 (All day) Washington Court Hotel 525 New Jersey Avenue NW, Washington DC 20001 Duke-Margolis' Gabriela Lavezzeri, PhD, MBA, Research Director and Scholar in Residence Edmund... Biomedical Innovation
Minimal Residual Disease as a Surrogate Endpoint in Hematologic Cancer Trials September 7, 2016 - 9:00 am to 4:00 pm Hotel Monaco 700 F Street, NW Washington, DC 20004 In order... Biomedical Innovation
Exploring Practical Implementation of Economic Incentives for Antimicrobial Development in the U.S. July 20, 2016 (All day) Marriott Marquis 901 Massachusetts Ave NW, Washington, DC 20001 Duke-Margolis convened an expert workshop to address the challenges facing antibiotic research...
Technology Industry Advisory Panel Workshop: The Business Case for Digital Health June 17, 2016 (All day) Stanford University The Duke-Margolis Center for Health Policy co-hosted an event on Digital Health with Stanford...
Building a Common Risk Evaluation and Mitigation Strategies (REMS) Platform Expert Workshop June 7, 2016 - 1:00 pm to 4:45 pm Over the last several years the U.S. Food and Drug Administration (FDA) has pursued a number of... Biomedical Innovation
Building a Common Risk Evaluation and Mitigation Strategies (REMS) Platform Public Meeting June 7, 2016 - 8:30 am to 12:15 pm Over the... Biomedical Innovation
Commonwealth Fund Roundtable May 20, 2016 (All day) 1201 New York Ave NW, Lobby Conference Room U.S. providers, payers and policy makers have found that current payment systems and regulations...
Biological Variability to Drug Response: Sex Difference in Clinical Trials May 16, 2016 (All day) We know there is biologic variability to drug response. What we don’t know is what those major... Biomedical Innovation
